Opendata, web and dolomites


Morphogenetically active blood vessels: Proof-of-Concept

Total Cost €


EC-Contrib. €






 MorphoVES-PoC project word cloud

Explore the words cloud of the MorphoVES-PoC project. It provides you a very rough idea of what is the project "MorphoVES-PoC" about.

preferentially    group    small    discovered    erc    implants    natural    disclose    mm    vessels    eptfe    polyphosphate    clear    handle    processed    gathered    frame    advantages    polymers    lt    functionally    bypass    expanded    cardiovascular    patients    durability    physiological    fabrication    economical    life    allowed    differentiation    formulations    biosynthesis    printable    likewise    diseases    besides    definitively    data    artificial    superior    potencies    extruder    biodegradable    unprecedented    modular    biomineral    gene    urgently    vessel    quality    disorders    anionic    worldwide    view    biocompatibility    made    performed    charged    strength    insufficient    blood    grafts    polytetrafluoroethylene    cationic    physical    materials    biomedical    convinced    268476    vascular    synthetic    active    morphogenetically    poc    biopolymers    unexpectedly    biofunctional    combine    home    backbone    toxic    sponge    linkers    bioactive    optimal    terephthalate    device    inorganic    requiring    clinics    msdvgs    bio    surgery    polyethylene    biosilica    causes    mortality    attractive    grant    pet    prostheses    diameter    incl    experimental   

Project "MorphoVES-PoC" data sheet

The following table provides information about the project.


Organization address
address: Langenbeckstrasse 1
city: Mainz
postcode: 55131

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 149˙962 €
 EC max contribution 149˙962 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2014-PoC
 Funding Scheme ERC-POC
 Starting year 2015
 Duration (year-month-day) from 2015-04-01   to  2016-09-30


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

'Cardiovascular diseases are the leading causes of mortality in Europe and worldwide. Currently, synthetic prostheses used in bypass vascular surgery are produced from polyethylene terephthalate [PET] and expanded polytetrafluoroethylene [ePTFE]. Those materials show less than optimal, insufficient biocompatibility and durability properties, especially if used for SMALL DIAMETER BLOOD VESSELS. Within the frame of ERC Advanced Grant “BIOSILICA” (From gene to biomineral: Biosynthesis and application of sponge biosilica; Grant No. 268476), we unexpectedly discovered that distinct natural, biodegradable and biofunctional polymers, including biosilica and inorganic polyphosphate (anionic), are not only bio-printable but also morphogenetically active. Likewise attractive is that those biopolymers can be functionally processed by non-toxic and charged (cationic) linkers with growth/differentiation potencies. Therefore, these formulations, backbone polymers and bioactive linkers, allowed the fabrication of unprecedented “Modular Small Diameter Vascular Grafts (MSDVGs)' which combine in an optimal way physical strength with physiological activity. Furthermore, the fabrication of the synthetic vessels is performed by a home-made, easy to handle, extruder device which has been developed by our group. Therefore, this new ERC-PoC project will provide small diameter (< 6 mm) blood vessel implants (incl. the fabrication device - the extruder) urgently required in clinics, with superior properties and at low-costs, at the end of the project. We are definitively convinced that, in view of their advantages, our vessels will be preferentially used for patients requiring bypass surgery. The experimental data gathered disclose that we have in hand a product with a clear biomedical application potential. Besides of their economical value, our new type of artificial blood vessel will certainly improve the quality of life and well-being of patients with cardiovascular disorders.'


year authors and title journal last update
List of publications.
2016 Werner E. G. Müller, Maximilian Ackermann, Emad Tolba, Meik Neufurth, Shunfeng Wang, Heinz C. Schröder, Xiaohong Wang
A bio-imitating approach to fabricate an artificial matrix for cartilage tissue engineering using magnesium-polyphosphate and hyaluronic acid
published pages: 88559-88570, ISSN: 2046-2069, DOI: 10.1039/C6RA17043A
RSC Adv. 6/91 2019-07-24
2015 Meik Neufurth, Xiaohong Wang, Emad Tolba, Bernhard Dorweiler, Heinz C. Schröder, Thorben Link, Bärbel Diehl-Seifert, Werner E. G. Müller
Modular Small Diameter Vascular Grafts with Bioactive Functionalities
published pages: e0133632, ISSN: 1932-6203, DOI: 10.1371/journal.pone.0133632
PLOS ONE 10/7 2019-07-24
2016 Xiaohong Wang, Heinz C. Schröder, Werner E. G. Müller
Polyphosphate as a metabolic fuel in Metazoa: A foundational breakthrough invention for biomedical applications
published pages: 11-30, ISSN: 1860-6768, DOI: 10.1002/biot.201500168
Biotechnology Journal 11/1 2019-07-24

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MORPHOVES-POC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MORPHOVES-POC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

PP-MAGIC (2020)

(Photo-)Control of Persisters: Targeting the Magic Spot

Read More  

HomoJuridicus (2019)

Homo Juridicus: Correcting Law's Behavioural Illiteracy

Read More  

CERQUTE (2020)

Certification of quantum technologies

Read More